- Home
- TOWN vs PTGX Comparison
TOWN vs PTGX Comparison
Compare TOWN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TOWN | PTGX |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 5.4B |
| IPO Year | 1999 | 2016 |
Fundamental Metrics
Financial Performance| Metric | TOWN | PTGX |
|---|---|---|
| Price | $34.36 | $82.17 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $41.00 | ★ $93.00 |
| AVG Volume (30 Days) | 384.9K | ★ 946.7K |
| Earning Date | 01-21-2026 | 02-20-2026 |
| Dividend Yield | ★ 3.18% | N/A |
| EPS Growth | ★ 11.95 | N/A |
| EPS | ★ 2.23 | 0.72 |
| Revenue | ★ $766,599,000.00 | $209,217,000.00 |
| Revenue This Year | $23.63 | N/A |
| Revenue Next Year | $29.20 | $288.98 |
| P/E Ratio | ★ $15.19 | $116.88 |
| Revenue Growth | ★ 14.10 | N/A |
| 52 Week Low | $29.43 | $33.70 |
| 52 Week High | $38.01 | $96.54 |
Technical Indicators
Market Signals| Indicator | TOWN | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 36.66 |
| Support Level | $32.82 | $84.11 |
| Resistance Level | $33.85 | $89.61 |
| Average True Range (ATR) | 0.63 | 3.19 |
| MACD | -0.14 | -1.01 |
| Stochastic Oscillator | 46.25 | 3.89 |
Price Performance
Historical ComparisonAbout TOWN TowneBank
Towne Bank is a financial services company that places special emphasis on serving the financial needs of individuals, commercial enterprises, and professionals, offering retail and commercial banking services to numerous markets in Virginia and North Carolina. The company has three reportable segments: the Banking Segment provides loan and deposit services to retail and commercial customers and provides commercial mortgage brokerage services and investment and asset management services, and the Realty Segment provides residential real estate services and mortgage loans. It also provides resort property management and residential and commercial title insurance, and the Insurance Segment provides a wide array of insurance products, including property, casualty, life, and health insurance.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.